Post-Merger Ownership Structure
Company: Core Scientific
The claim, verbatim
Following the transaction, former Core Scientific stockholders owned 90.7% of the company, former XPDI public stockholders owned 6.7%, and XPDI sponsor owned 2.6%.
Source (primary)
Core Scientific 10-Q filed 2022-08-22 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗
Quote: “Following the Transaction, former Core Scientific stockholders owned 90.7 %, former XPDI public stockholders owned 6.7 % and XPDI's sponsor owned 2.6 % of the issued and outstanding shares of common stock, respectively, of the Company, excluding the impact of unvested restricted stock units and options.”
How we checked this
Checked on September 22, 2026. The cited source supports every part of this claim.
The document reports the exact post-transaction ownership percentages of 90.7%, 6.7%, and 2.6%.
Confirmed in the source:
- Former Core Scientific stockholders owned 90.7% after the transaction
- Former XPDI public stockholders owned 6.7%
- XPDI's sponsor owned 2.6%
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1839341/000162828022023382/core-20220630.htm) in full (555,145 characters, retrieved September 13, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific 10-Q filed 2022-08-22
Quote: “Following the Transaction, former Core Scientific stockholders owned 90.7 %, former XPDI public stockholders owned 6.7 % and XPDI's sponsor owned 2.6 % of the issued and outstanding shares of common stock, respectively, of the Company, excluding the impact of unvested restricted stock units and options.”